The China Food and Drug Administration (CFDA) is proposing the exemption of a further 28 types of medical device from clinical trials.
The list of products in the draft plan is made up of 22 types of Class II medical device and six Class III medical devices.
Comments on the proposal can be submitted until June 20, 2017. Contact us
today for more information on the proposed changes and to discover how regulatory intelligence and registration management system LICENSALE.COM®
assists MedTech firms in gaining access to 100+ markets faster and more cost-effectively than ever before.